Ensysce Biosciences (ENSCW) Revenue (2020 - 2025)
Ensysce Biosciences (ENSCW) reported Revenue of $493104.0 for Q3 2025, down 85.58% year-over-year from $3.4 million in Q3 2024, and down 64.04% quarter-over-quarter from $1.4 million in Q2 2025.
Ensysce Biosciences (ENSCW) Revenue (2020 - 2025) Analysis & Trends
Ensysce Biosciences (ENSCW) has 6 years of Revenue data on file, last reported at $493104.0 in Q3 2025.
- Revenue for Q3 2025 came in at $493104.0, down 85.58% year-over-year; the trailing twelve-month figure through Sep 2025 was $4.5 million (up 1.51% YoY), and the FY2024 annual result was $5.2 million, up 133.58% from the prior year.
- Revenue eased to $493104.0 in Q3 2025 per ENSCW's latest filing, from $1.4 million in the prior quarter.
- Over five years, Revenue peaked at $3.4 million in Q3 2024 and troughed at $181797.0 in Q2 2024.
- A 5-year average of $877865.6 and a median of $515032.0 in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2024 and 2025: Revenue jumped 685.26% in 2024, then tumbled 85.58% in 2025.
- A 5-year view of Revenue shows it stood at $1.6 million in 2021, then retreated by 12.34% to $1.4 million in 2022, then sank by 64.07% to $515032.0 in 2023, then soared by 153.12% to $1.3 million in 2024, then slumped by 62.18% to $493104.0 in 2025.
- Business Quant data shows ENSCW's Revenue at $493104.0 in Q3 2025, $1.4 million in Q2 2025, and $1.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ensysce Biosciences | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 493,104.00 |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | 181,797.00 |
| Mar 31, 2024 | 305,722.00 |
| Dec 31, 2023 | 515,032.00 |
| Sep 30, 2023 | 435,380.00 |
| Jun 30, 2023 | 490,472.00 |
| Mar 31, 2023 | 789,635.00 |
| Dec 31, 2022 | 1.43 Mn |
| Sep 30, 2022 | 279,351.00 |
| Jun 30, 2022 | 207,471.00 |
| Mar 31, 2022 | 603,098.00 |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 444,516.00 |
| Mar 31, 2021 | 250,576.00 |
| Dec 31, 2020 | 416,489.00 |